F-group (family)
5.1.3.26 BNR_2
Ligands and drugs
111
Member domains
63
with ligand contacts (≤ 4 Å)
56.8% of members
61
with DrugDomain annotations
55.0% of members
47
with a DrugBank compound
42.3% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 5.1.3.26 belongs to X-group 5 beta-propeller-like, which binds 7.8 ligand superclasses per 20 proteins, broader than 52% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03991 | DAN | 2-deoxy-2,3-dehydro-N-acetylneuraminic acid | 11 |
| DB03721 | SIA | N-acetyl-alpha-neuraminic acid | 3 |
| DB04694 | FKD | 2,6-anhydro-3-deoxy-3-fluoronononic acid | 3 |
| DB00141 | NAG | N-Acetylglucosamine | 2 |
| DB00198 | — | — | 2 |
| DB12529 | NO2 | Nitrite | 2 |
| DB00482 | — | Celecoxib | 1 |
| DB00558 | ZMR | Zanamivir | 1 |
| DB00945 | — | Acetylsalicylic acid | 1 |
| DB01716 | CNP | 2-propenyl-N-acetyl-neuramic acid | 1 |
| DB04211 | FSI | 5-(acetylamino)-3,5-dideoxy-3-fluoro-D-erythro-alpha-L-manno-non-2-ulopyranosonic acid | 1 |
| DB06614 | BCZ | Peramivir | 1 |
| DB07960 | IEM | 5-ACETAMIDO-5,6-DIHYDRO-4-HYDROXY-6-ISOBUTOXY-4H-PYRAN-2-CARBOXYLIC ACID | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| CL | CHLORIDE ION | 13 |
| NAmetal | SODIUM ION | 13 |
| DAN | 2-DEOXY-2,3-DEHYDRO-N-ACETYL-NEURAMINIC ACID | 11 |
| CAmetal | CALCIUM ION | 6 |
| KDM | deamino-alpha-neuraminic acid | 5 |
| KFN | 2,6-anhydro-3-deoxy-D-glycero-D-galacto-non-2-enonic acid | 4 |
| SIA | N-acetyl-alpha-neuraminic acid | 4 |
| FKD | 3-deoxy-3-fluoro-D-erythro-alpha-L-manno-non-2-ulopyranosonic acid | 3 |
| K99 | (2R,3R,4R,5R,6S)-2,3-bis(fluoranyl)-4,5-bis(oxidanyl)-6-[(1R,2R)-1,2,3-tris(oxidanyl)propyl]oxane-2-carboxylic acid | 3 |
| UNL | Unknown ligand | 3 |
| NAG | 2-acetamido-2-deoxy-beta-D-glucopyranose | 2 |
| NO2 | NITRITE ION | 2 |
| SKD | 2-ACETYLAMINO-7-(1,2-DIHYDROXY-ETHYL)-3-HYDROXY-6,8-DIOXA-BICYCLO[3.2.1]OCTANE-5-CARBOXYLIC ACID | 2 |
| 5N6 | 9-O-acetyl-5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranosonic acid | 1 |
| BCZ | 3-(1-ACETYLAMINO-2-ETHYL-BUTYL)-4-GUANIDINO-2-HYDROXY-CYCLOPENTANECARBOXYLIC ACID | 1 |
| CDmetal | CADMIUM ION | 1 |
| CNP | 2-propenyl-N-acetyl-neuraminic acid | 1 |
| DYM | (2R)-2,3-dihydroxypropyl 2-acetamido-2,4-dideoxy-alpha-L-threo-hex-4-enopyranosiduronic acid | 1 |
| FSI | 5-acetamido-3,5-dideoxy-3-fluoro-D-erythro-alpha-L-manno-non-2-ulopyranosonic acid | 1 |
| FSR | (2S,3S,4R,5R,6R)-5-acetamido-2,3-bis(fluoranyl)-4-oxidanyl-6-[(1S,2S)-1,2,3-tris(oxidanyl)propyl]oxane-2-carboxylicacid | 1 |